Posted on November 24, 2017
InSyBio is the latest startup company to join the International Accelerator program in Austin, Texas USA (https://www.internationalaccelerator.com/) with an ultimate goal to get access to the USA biotechnology market.
Labros Digonis, the CEO of InSyBio, who holds a MBA and Master’s Degree in Naval Architecture & Marine Engineering and has over 30 years of experience in top-management positions in multibillion groups and as management consultant in several Industries, stated about InSyBio’s collaboration with the International Accelerator that "We don’t only share common interests but the same vision and passion which trancends a common partnership; it’s a strategic alliance to create something great to not only serve America but the World!"
InSyBio joined IA’s program to expand their operations in North America, as well as gain access to institutional investors to expedite their growth. IA’s program is unique as they invest exclusively in foreign-born entrepreneurs. The 12-month customized program is designed for portfolio companies to gain access to the U.S. market and secure venture capital funding for growth opportunities. In addition, each portfolio companies receives a hand selected mentor, a deep dive strategic and operational roadmap to success, 12-months of free working space, $50,000 in seed funding, and a host of other value-add services.
About InSyBio: InSyBio is a privately held, global bioinformatics company (www.insybio.com) focusing, through advanced biological big-data computational tools, on biomarkers discovery for Cancer, Neurodegenerative diseases and Nutrition. Biomarker extraction from biological big data (genomics, transcriptomics, proteomics, etc.) is essential for drug discovery & research acceleration, personalized medicine and Nutrition.
InSyBio’s patented breakthrough technology offers unique inside path to an integrated end-to-end accurate biomarker discovery process, simultaneous integration of data from different sources and types and has demonstrated ability to locate significantly more common proteins in large scale proteomics datasets. At InSyBio, the team is passionate about supporting customers to minimize their efforts, as they design and develop new drugs, therapeutic and diagnostic methods.
About International Accelerator: The International Accelerator is the only U.S. accelerator focused solely on investing in companies with non-U.S. citizen founders. IA provides access to seed funding, quality mentors, and services foreign-born entrepreneurs need to scale up their businesses in the United States. The International Accelerator is more than an accelerator program. It is a trusted co-founder for stateside ventures and dedicated to helping non-U.S. citizen entrepreneurs set up their U.S. company, give it an “American look and feel,” and lay a sturdy foundation to build a global business. The experienced team leverages years of international business, design, and entrepreneurial expertise, as well as access to industry experts, active investors and potential customers. At IA, the goal is to bring startups in and send them out with impressive products and the capability to stand on their own feet. Being entrepreneurs themselves, they clearly know the hardships and worries of the startup process. Apart from money, IA is always available to give the help customized for the founder, so they can focus on their product and developing their vision for the company.
For more News visit our InSyBio Blog.